Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
26
CULP Quote, Financials, Valuation and Earnings
Last price:
$3.85
Seasonality move
:
2.99%
Day range:
$3.67 - $3.94
52-week range:
$3.42 - $6.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.22x
P/B ratio:
0.78x
Volume:
11.4K
Avg. volume:
25K
1-year change:
-19.96%
Market cap:
$46.3M
Revenue:
$225.3M
EPS (TTM):
-$1.75
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Culp has 116.8% upside to fair value with a price target of -- per share.
CULP vs. S&P 500
-
Over the past 5 trading days, Culp has overperformed the S&P 500 by 3.69% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Culp does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Culp revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Culp reported revenues of $52.3M.
Earnings Growth
-
Culp earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Culp reported earnings per share of -$0.33.
Enterprise value:
44.7M
EV / Invested capital:
--
Price / LTM sales:
0.22x
EV / EBIT:
--
EV / Revenue:
0.21x
PEG ratio (5yr expected):
-0.04x
EV / Free cash flow:
-3.07x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$22.6M
Return On Assets:
-16.6%
Net Income Margin (TTM):
-10.23%
Return On Equity:
-31.34%
Return On Invested Capital:
-30.18%
Operating Margin:
-4.27%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $230.4M | $237.2M | $214M | $60.4M | $52.3M | |
| Gross Profit | $7.8M | $29.6M | $22.6M | $7.7M | $6.3M | |
| Operating Income | -$28.5M | -$10.6M | -$13.9M | -$1.8M | -$2.2M | |
| EBITDA | -$22M | -$5.1M | -$14M | -$417K | -$2.3M | |
| Diluted EPS | -$2.68 | -$1.10 | -$1.75 | -$0.26 | -$0.33 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $148.6M | $130.5M | $93M | $89.1M | $85.3M | |
| Total Assets | $212M | $211.6M | $150.6M | $142M | $127.6M | |
| Current Liabilities | $62.4M | $59.2M | $36.4M | $43.4M | $50.6M | |
| Total Liabilities | $83.6M | $84.8M | $57.1M | $61.2M | $67.9M | |
| Total Equity | $128.4M | $126.7M | $93.5M | $80.8M | $59.7M | |
| Total Debt | -- | -- | -- | -- | $5.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$489K | -$2.7M | -$11.7M | -$1.5M | -$6.8M | |
| Cash From Investing | $7.4M | -$941K | -$925K | -$1.1M | $167K | |
| Cash From Financing | -$1.7M | -$260K | $5.4M | -- | $1.4M | |
| Free Cash Flow | -$2.5M | -$6.5M | -$14.6M | -$2.8M | -$7.7M | |
CULP
Sector
Market Cap
$46.3M
$401M
Price % of 52-Week High
53.87%
66.47%
Dividend Yield
0%
0%
Shareholder Yield
--
3.88%
1-Year Price Total Return
-19.96%
-17.67%
Beta (5-Year)
1.006
0.832
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.75
200-day SMA
Sell
Level
$5.21
Bollinger Bands (100)
Sell
Level
4.47 - 5.67
Chaikin Money Flow
Sell
Level
-260.7K
20-day SMA
Sell
Level
$4.01
Relative Strength Index (RSI14)
Sell
Level
36.54
ADX Line
Sell
Level
56.4
Williams %R
Neutral
Level
-68.5315
50-day SMA
Sell
Level
$4.72
MACD (12, 26)
Buy
Level
0.24
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Sell
Level
-314.4K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7583)
Buy
CA Score
(Annual)
Level (0.1898)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (1.6293)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.
Stock Forecast FAQ
In the current month, CULP has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CULP average analyst price target in the past 3 months is --.
-
Where Will Culp Stock Be In 1 Year?
According to analysts, the consensus estimate is that Culp share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Culp?
Analysts are divided on their view about Culp share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Culp is a Sell and believe this share price will drop from its current level to --.
-
What Is Culp's Price Target?
The price target for Culp over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CULP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Culp is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CULP?
You can purchase shares of Culp via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Culp shares.
-
What Is The Culp Share Price Today?
Culp was last trading at $3.85 per share. This represents the most recent stock quote for Culp. Yesterday, Culp closed at $3.69 per share.
-
How To Buy Culp Stock Online?
In order to purchase Culp stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
